Fluctuations in serum lipid levels during neoadjuvant treatment as novel predictive and prognostic biomarkers for locally advanced breast cancer: a retrospective analysis based on a prospective cohort.

MLA

Chen, Xinru, et al. “Fluctuations in Serum Lipid Levels during Neoadjuvant Treatment as Novel Predictive and Prognostic Biomarkers for Locally Advanced Breast Cancer: A Retrospective Analysis Based on a Prospective Cohort.” Lipids in Health & Disease, vol. 23, no. 1, Aug. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12944-024-02140-x.

APA

Chen, X., Zhao, Y., Wang, Y., Ye, Y., Xu, S., Zhou, L., Lin, Y., Lu, J., & Yin, W. (2024). Fluctuations in serum lipid levels during neoadjuvant treatment as novel predictive and prognostic biomarkers for locally advanced breast cancer: a retrospective analysis based on a prospective cohort. Lipids in Health & Disease, 23(1), 1–15. https://doi.org/10.1186/s12944-024-02140-x

Chicago

Chen, Xinru, Yingying Zhao, Yaohui Wang, Yumei Ye, Shuguang Xu, Liheng Zhou, Yanping Lin, Jingsong Lu, and Wenjin Yin. 2024. “Fluctuations in Serum Lipid Levels during Neoadjuvant Treatment as Novel Predictive and Prognostic Biomarkers for Locally Advanced Breast Cancer: A Retrospective Analysis Based on a Prospective Cohort.” Lipids in Health & Disease 23 (1): 1–15. doi:10.1186/s12944-024-02140-x.